SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-20-000156
Filing Date
2020-08-14
Accepted
2020-08-13 20:01:11
Documents
51
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 621183
2 302 CERTIFICATE exh31-1.htm EX-31.1 7460
3 906 CERTIFICATE exh32-1.htm EX-32.1 2594
  Complete submission text file 0001136261-20-000156.txt   3313805

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT seel-20200630.xml EX-101.INS 457983
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT seel-20200630.xsd EX-101.SCH 51436
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT seel-20200630_cal.xml EX-101.CAL 68384
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT seel-20200630_def.xml EX-101.DEF 156081
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT seel-20200630_lab.xml EX-101.LAB 394067
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT seel-20200630_pre.xml EX-101.PRE 312081
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 201100921
SIC: 2834 Pharmaceutical Preparations